Trademark Overview
On Wednesday, March 11, 2026, a trademark application was filed for NOVARTIS with the United States Patent and Trademark Office. The USPTO has given the NOVARTIS trademark a serial number of 79452038. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 18, 2026. This trademark is owned by Novartis AG. The NOVARTIS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations used in organ transplantation; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use
